Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. Research & Clinical Trial Webinars,Webinars 3 years ago You may also like 51:49 Webinar: INSPIRE DUCHENNE Clinical Trial Update and Study Expansion 14 hours ago Research & Clinical Trial Webinars,Webinars sgt-003,solid biosciences 56:19 Webinar: Exploring Muscle Regeneration – A New Approach with Satellos 2 weeks ago Research & Clinical Trial Webinars,Webinars 44:01 World Muscle Society 2024: CIFFREO Data Discussion with Pfizer 4 weeks ago Research & Clinical Trial Webinars,Webinars fordadistrogene movaparvovec,pfizer 59:49 Webinar: SHIELD DMD – A Bone Health Study in Duchenne 1 month ago Research & Clinical Trial Webinars,Webinars satralizumab 43:40 Webinar: Interim Results from FORWARD-53 Study of WVE-N531 in Duchenne Muscular Dystrophy 1 month ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 51:42 Webinar: Overview of DUVYZAT and Access Resources (September 2024) 2 months ago Research & Clinical Trial Webinars,Webinars 1:04:54 Webinar: Advocating for A Successful School Year (September 2024) 2 months ago Care Webinars,Webinars 1:01:24 Webinar: PPMD Advocacy – Raising Our Voices in 2024 and Beyond [Sep 2024] 2 months ago Webinars 123…25»Page 1 of 25
by: Parent Project Muscular Dystrophy
![Webinar: PPMD Advocacy - Raising Our Voices in 2024 and Beyond [Sep 2024]](https://img.youtube.com/vi/sHbI1e3yNdw/maxresdefault.jpg)